trial · primary record
Inclisiran sodium 300 mg
Coronary Artery Disease
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 610 |
| Primary completion | 2026-10-27 |
| Primary endpoint | Percentage change in total coronary atheroma volume |
| Registry ID | NCT05360446 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:39.419Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05360446
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.